ORIC
Oric Pharmaceuticals, Inc.Company Information
- Company Name
- Oric Pharmaceuticals, Inc.
- CIK
- CIK0001796280
- Category
- Non-accelerated filer
- Ticker: Exchange
- ORIC: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ORIC
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-06-23
- Last sale
- 2026-09-28
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 310,076
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 117,297,534
- Shares outstanding
- 108,012,388
- Ownership
- 108.60%
Earnings Market Reaction
- Filing date
- 2026-08-03
- Price on filing date
- —
- 1-month reaction
- 24.91%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 37 | 56 | 46 | 50 | 76 | 49 | 59 | 44 | 50 | 56 | 23 | 26 | ||||||
| Available For Sale Securities Debt Securities Current | 227 | 226 | 236 | 237 | 207 | 154 | 197 | 228 | 237 | 260 | 185 | 201 | ||||||
| Prepaid Expense And Other Assets Current | 9 | 8 | 7 | 8 | 9 | 8 | 6 | 7 | 8 | 7 | 4 | 5 | ||||||
| Assets Current | 274 | 290 | 288 | 296 | 291 | 211 | 262 | 279 | 295 | 324 | 213 | 232 | ||||||
| Available For Sale Securities Debt Securities Noncurrent | 123 | 138 | 111 | 126 | 45 | 20 | 0 | 10 | 22 | 15 | 27 | 29 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Other Assets Noncurrent | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 | 9 | 9 | 10 | 10 | ||||||
| Assets | 405 | 437 | 409 | 431 | 347 | 243 | 274 | 302 | 329 | 351 | 252 | 274 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 3 | 4 | 3 | 3 | 5 | 2 | 4 | 2 | 3 | 1 | 4 | ||||||
| Accrued Liabilities Current | 17 | 15 | 17 | 17 | 15 | 12 | 23 | 17 | 17 | 12 | 20 | 15 | ||||||
| Liabilities Current | 21 | 18 | 20 | 20 | 18 | 18 | 25 | 21 | 20 | 15 | 20 | 19 | ||||||
| Other Liabilities Noncurrent | 3 | 3 | 4 | 4 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | ||||||
| Liabilities | 23 | 21 | 25 | 24 | 23 | 23 | 31 | 28 | 27 | 22 | 28 | 27 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,152 | 1,144 | 1,076 | 1,068 | 953 | 812 | 806 | 800 | 795 | 789 | 659 | 654 | ||||||
| Retained Earnings Accumulated Deficit | -770 | -728 | -692 | -662 | -629 | -593 | -563 | -526 | -492 | -460 | -435 | -407 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -0 | 1 | 1 | 0 | 0 | 0 | 1 | -0 | -0 | 0 | -0 | ||||||
| Stockholders Equity | 381 | 416 | 384 | 407 | 324 | 220 | 243 | 274 | 302 | 329 | 224 | 247 | ||||||
| Liabilities And Stockholders Equity | 405 | 437 | 409 | 431 | 347 | 243 | 274 | 302 | 329 | 351 | 252 | 274 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Common Stock Shares Issued | 104 | 103 | 99 | 97 | 86 | 71 | 71 | 71 | 68 | 67 | 55 | 55 | ||||||
| Shares Outstanding | 104 | 103 | 99 | 97 | 86 | 71 | 71 | 71 | 68 | 67 | 55 | 55 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOric Pharmaceuticals, Inc. (ORIC) — SEC Financial Statements & Analysis
Oric Pharmaceuticals, Inc. (ORIC) is a pharmaceutical preparations company, incorporated in DE. Oric Pharmaceuticals, Inc. trades on Nasdaq as: ORIC. Oric Pharmaceuticals, Inc. (ORIC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, Oric Pharmaceuticals, Inc. carries a market cap of $1.17B, a P/E ratio of -8.33x, a P/B ratio of 3.07x, an enterprise value of $1.13B, and an EV/EBITDA multiple of -7.30x. On profitability, it posts a Return on Equity (ROE) of -39.80%, a Return on Assets (ROA) of -37.35%, and a Return on Invested Capital (ROIC) of -52.80%. Per share, it reports EPS of $-1.30, diluted EPS of $-1.30, free cash flow per share of $-1.04, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 2.26% year-over-year and EPS growth of -26.03% year-over-year. On the balance sheet, it maintains a current ratio of 13.19x, a quick ratio of 12.76x, working capital of $252.94M, a debt-to-equity ratio of 0.06x, a debt ratio of 0.06, an interest coverage ratio of -63.92x, free cash flow of $-112.26M (TTM), and net debt of $-37.97M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.17B
- P/E TTM
- -8.33x
- EPS TTM
- $-1.30
- P/B TTM
- 3.07x
- ROE TTM
- -39.80%
- ROA TTM
- -37.35%
- Debt To Equity
- 0.06x
- Free Cash Flow TTM
- $-112.26M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Oric Pharmaceuticals, Inc. in?
Oric Pharmaceuticals, Inc. (ORIC) operates in the Pharmaceutical Preparations industry.
What exchange does ORIC trade on?
Oric Pharmaceuticals, Inc. (ORIC) trades on the Nasdaq.
Where is Oric Pharmaceuticals, Inc. incorporated?
Oric Pharmaceuticals, Inc. is incorporated in DE.
When was Oric Pharmaceuticals, Inc. (ORIC)'s most recent SEC filing?
Oric Pharmaceuticals, Inc. (ORIC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03.
What is ORIC's market cap?
Oric Pharmaceuticals, Inc. (ORIC) has a market capitalization of $1.17B as of 2026-06-30.
What is ORIC's EPS (earnings per share)?
Oric Pharmaceuticals, Inc. (ORIC)'s trailing twelve month EPS is $-1.30 as of 2026-06-30.
What is ORIC's ROE (return on equity)?
Oric Pharmaceuticals, Inc. (ORIC)'s trailing twelve month Return on Equity (ROE) is -39.80% as of 2026-06-30.
What is ORIC's ROA (return on assets)?
Oric Pharmaceuticals, Inc. (ORIC)'s trailing twelve month Return on Assets (ROA) is -37.35% as of 2026-06-30.
What is ORIC's ROIC (return on invested capital)?
Oric Pharmaceuticals, Inc. (ORIC)'s trailing twelve month Return on Invested Capital (ROIC) is -52.80% as of 2026-06-30.
What is ORIC's EV/EBITDA?
Oric Pharmaceuticals, Inc. (ORIC)'s trailing twelve month EV/EBITDA is -7.30x as of 2026-06-30.